Octreotide

Synopsis, Chemistry

APIs // Active Pharmaceutical Ingredients

42 Suppliers, 25 USDMF, 5 CEP/COS, 4 JDMF, 5 EU WC, 1 KDMF, 18 NDC API, 24 Listed Suppliers

DEVELOPMENTS

21 Drug(s) in Development

21 Drug(s) in Development

PRICE INFORMATION

API Reference Price, API Exports, API Imports, FDF Imports

DOSSIERs // Finished Dosage Forms

181 Dossiers, 59 FDA Orange Book, 72 Europe, 7 Canada, 26 Australia, 2 South Africa, 15 Listed Dossiers

DRUG PRODUCT COMPOSITION

INJECTABLE;INJECTION - EQ 0.05MG BASE/ML, INJECTABLE;INJECTION - EQ 0.1MG BASE/ML, INJECTABLE;INJECTION - EQ 0.2MG BASE/ML **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, INJECTABLE;INJECTION - EQ 0.5MG BASE/ML, INJECTABLE;INJECTION - EQ 1MG BASE/ML **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

RELATED EXCIPIENT COMPANIES

Suppliers, 13 SPI Pharma, 3 Roquette, 2 Gangwal Chemicals, 2 Microlex e.U, 2 Kerry, 2 Gangwal Healthcare, 2 Actylis, 1 Pfanstiehl, 1 DKSH, 1 BASF, 1 Shijiazhuang Huaxu Pharmaceutical, 1 Finar, 1 Shanghai Shenmei Pharmaceutical Technology Co., Ltd, 1 Rochem International Inc, 1 Sigachi Industries, 1 Ingredion Pharma Solutions

EXCIPIENTS BY APPLICATIONS

18 Fillers, Diluents & Binders, 10 Chewable & Orodispersible Aids, 10 Direct Compression, 9 Taste Masking, 6 Parenteral, 4 Co-Processed Excipients, 3 Disintegrants & Superdisintegrants, 3 Granulation, 2 API Stability Enhancers, 1 Thickeners and Stabilizers, 1 Topical

GLOBAL SALES INFORMATION

18 US Medicaid Prescriptions, 59 Finished Drug Prices

MARKET PLACE

13 APIs, 14 DOSSIERS // FDF

PATENTS

12 US Patents

12 US Patents

ANALYTICAL SOLUTION(s)

2 USP Standards, 6 Other Ref. Standards

DIGITAL CONTENT

1 Data Compilation & Company Tracker #PharmaFlow, 36 News

Drug Approvals by the Medicines Control Council in South Africa containing Octreotide. Original Data : South African Medicines Price Registry

Octreotide

Synopsis

Chemistry

APIs // Active Pharmaceutical Ingredients

42 Suppliers

25 USDMF

5 CEP/COS

4 JDMF

5 EU WC

1 KDMF

18 NDC API

24 Listed Suppliers

DEVELOPMENTS

21 Drug(s) in Development

PRICE INFORMATION

API Reference Price

API Exports

API Imports

FDF Imports

DOSSIERs // Finished Dosage Forms

181 Dossiers

59 FDA Orange Book

72 Europe

7 Canada

26 Australia

2 South Africa

15 Listed Dossiers

DRUG PRODUCT COMPOSITION

INJECTABLE;INJECTION - EQ 0.05MG BASE/ML

INJECTABLE;INJECTION - EQ 0.1MG BASE/ML

INJECTABLE;INJECTION - EQ 0.2MG BASE/ML **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

INJECTABLE;INJECTION - EQ 0.5MG BASE/ML

INJECTABLE;INJECTION - EQ 1MG BASE/ML **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

RELATED EXCIPIENT COMPANIES

Suppliers

13 SPI Pharma

3 Roquette

2 Gangwal Chemicals

2 Microlex e.U

2 Kerry

2 Gangwal Healthcare

2 Actylis

1 Pfanstiehl

1 DKSH

1 BASF

1 Shijiazhuang Huaxu Pharmaceutical

1 Finar

1 Shanghai Shenmei Pharmaceutical Technology Co., Ltd

1 Rochem International Inc

1 Sigachi Industries

1 Ingredion Pharma Solutions

EXCIPIENTS BY APPLICATIONS

18 Fillers, Diluents & Binders

10 Chewable & Orodispersible Aids

10 Direct Compression

9 Taste Masking

6 Parenteral

4 Co-Processed Excipients

3 Disintegrants & Superdisintegrants

3 Granulation

2 API Stability Enhancers

1 Thickeners and Stabilizers

1 Topical

GLOBAL SALES INFORMATION

18 US Medicaid Prescriptions

59 Finished Drug Prices

MARKET PLACE

13 APIs

14 DOSSIERS // FDF

PATENTS

12 US Patents

ANALYTICAL SOLUTION(s)

2 USP Standards

6 Other Ref. Standards

DIGITAL CONTENT

1 Data Compilation & Company Tracker #PharmaFlow

36 News

Octreotide

Teva Pharmaceuticals (Pty) Ltd

INJECTABLE;INJECTION - EQ 0.2MG BASE/ML Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons

INJECTABLE;INJECTION - EQ 1MG BASE/ML Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons